ATE451475T1 - Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben - Google Patents

Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben

Info

Publication number
ATE451475T1
ATE451475T1 AT04777581T AT04777581T ATE451475T1 AT E451475 T1 ATE451475 T1 AT E451475T1 AT 04777581 T AT04777581 T AT 04777581T AT 04777581 T AT04777581 T AT 04777581T AT E451475 T1 ATE451475 T1 AT E451475T1
Authority
AT
Austria
Prior art keywords
cns
systems
nervous system
central nervous
samples
Prior art date
Application number
AT04777581T
Other languages
English (en)
Inventor
Osvaldo Podhajcer
Fernando Pitossi
Marcelo Rubinstein
Original Assignee
Gentron Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentron Llc filed Critical Gentron Llc
Application granted granted Critical
Publication of ATE451475T1 publication Critical patent/ATE451475T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04777581T 2003-07-03 2004-07-02 Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben ATE451475T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48472603P 2003-07-03 2003-07-03
US48468303P 2003-07-03 2003-07-03
PCT/US2004/021543 WO2005007892A1 (en) 2003-07-03 2004-07-02 Methods and systems for diagnosis of non-cenral nervous system (cns) diseases in cns samples

Publications (1)

Publication Number Publication Date
ATE451475T1 true ATE451475T1 (de) 2009-12-15

Family

ID=34083317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04777581T ATE451475T1 (de) 2003-07-03 2004-07-02 Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben

Country Status (8)

Country Link
US (2) US20060263783A1 (de)
EP (1) EP1649062B1 (de)
JP (1) JP2007531494A (de)
AT (1) ATE451475T1 (de)
AU (1) AU2004258101B2 (de)
CA (1) CA2531281A1 (de)
DE (1) DE602004024539D1 (de)
WO (1) WO2005007892A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2094871A4 (de) * 2006-11-16 2010-03-31 Gentron Llc Verfahren, systeme und zusammensetzungen zur diagnose von krebs
JP2010533869A (ja) 2007-07-16 2010-10-28 カリフォルニア インスティチュート オブ テクノロジー 標的分子を検出するためのマイクロ流体装置、方法及びシステム
JPWO2009020058A1 (ja) 2007-08-03 2010-11-04 学校法人慶應義塾 脱髄病変へのドラッグデリバリーシステム及び脱髄病変の生化学的マーカー
WO2009051238A1 (ja) * 2007-10-18 2009-04-23 Riken ヒト白血病幹細胞および白血病非幹細胞が増幅されたマウスおよびその製造方法
WO2010030293A1 (en) * 2008-09-15 2010-03-18 Gentron, Inc. Methods, systems, and compositions for cancer diagnosis
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
JP2011149859A (ja) * 2010-01-22 2011-08-04 Igaku Seibutsugaku Kenkyusho:Kk 食道癌マーカー
US20130151197A1 (en) * 2011-11-23 2013-06-13 General Electric Company Automated performance measurement processes and systems
US8912159B2 (en) * 2012-02-24 2014-12-16 National Institutes Of Health (Nih) Analyzing semaphorin7a (Sema7A) levels for assessing cancer metastatic potential and methods of treatment
CN104884605B (zh) 2012-08-24 2018-05-18 耶鲁大学 用于高通量多重检测的系统、装置和方法
EP3227684B1 (de) 2014-12-03 2019-10-02 Isoplexis Corporation Analyse und screening für die sekretionprofile von zellen
US11353448B2 (en) 2015-02-13 2022-06-07 California Institute Of Technology Methods and compositions for quantifying metabolites and proteins from single cells
EA037995B1 (ru) * 2015-02-24 2021-06-21 Рупрехт-Карлс-Университет Гейдельберг Панель биомаркеров для обнаружения рака
US20200166518A1 (en) 2016-09-12 2020-05-28 IsoPlexis Corporation System and methods for multiplexed analysis of cellular and other immunotherapeutics
US11493508B2 (en) 2016-11-11 2022-11-08 IsoPlexis Corporation Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells
US11525783B2 (en) 2016-11-22 2022-12-13 IsoPlexis Corporation Systems, devices and methods for cell capture and methods of manufacture thereof
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
KR102207697B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR20210000253A (ko) * 2019-12-16 2021-01-04 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207696B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207699B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102100588B1 (ko) * 2019-06-24 2020-04-13 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207698B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR20210000255A (ko) * 2019-12-16 2021-01-04 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
CN115176158A (zh) 2020-02-27 2022-10-11 伊索普莱克西斯公司 用于多路分析的系统、装置及方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005864A1 (en) * 1993-08-27 1995-03-02 Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Convection-enhanced drug delivery
EP1132473A4 (de) * 1998-11-20 2002-06-12 Fuso Pharmaceutical Ind Serinprotease bssp6
BR0008480A (pt) * 1999-02-23 2002-10-22 Warner Lambert Co Sistema e processo para controle e apresentação de informação derivada de determinação do perfil de expressão de gene
AU773329B2 (en) * 1999-05-14 2004-05-20 Proteomedica Ab Materials and methods relating to disease diagnosis
EP1274861B1 (de) * 2000-03-27 2009-12-23 Thomas Jefferson University Zusammensetzungen und methoden zur identifizierung von krebszellen
US6372250B1 (en) * 2000-04-25 2002-04-16 The Regents Of The University Of California Non-invasive gene targeting to the brain
US7105293B2 (en) * 2000-09-19 2006-09-12 Whitehead Institute For Biomedical Research Genetic markers for tumors
US20030064385A1 (en) * 2001-05-16 2003-04-03 Dressman Marlene Michelle Genes expressed in breast cancer as prognostic and therapeutic targets
CN1612936A (zh) * 2001-11-09 2005-05-04 苏尔斯精细医药公司 利用基因表达分布图识别、监控和治疗疾病以及鉴定生物学状态

Also Published As

Publication number Publication date
US20060263783A1 (en) 2006-11-23
EP1649062A1 (de) 2006-04-26
DE602004024539D1 (de) 2010-01-21
CA2531281A1 (en) 2005-01-27
AU2004258101A1 (en) 2005-01-27
AU2004258101B2 (en) 2010-12-23
WO2005007892A1 (en) 2005-01-27
JP2007531494A (ja) 2007-11-08
US20110251077A1 (en) 2011-10-13
EP1649062B1 (de) 2009-12-09

Similar Documents

Publication Publication Date Title
DE602004024539D1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
WO2005052592A3 (en) Methods for diagnosis, stratification, and monitoring of alzheimer’s disease
EP4257705A3 (de) Biomarker für traumatische hirnverletzungen
WO2007033216A3 (en) Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
EA200600920A1 (ru) Иммуносорбентные исследования крови для оценки пароксизмальных церебральных разрядов
NO20070949L (no) Transkriptomdiagnostikk i spytt
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
WO2007080597A3 (en) Polynucleotide and polypeptide sequences and methods for diagnosis
ATE511651T1 (de) Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen
EP2365335A3 (de) Diagnoseverfahren
WO2004045376A3 (en) Screening methods to identify treatments for autoimmune disease
WO2007032876A3 (en) Biomarkers associated with age-related macular degeneration
WO2006059252A3 (en) Methods and fluorinated compositions for treating amyloid-related diseases
WO2008008487A3 (en) Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
ATE470153T1 (de) Diagnostische verfahren für therapeutische verbindungen sowie verfahren zur überwachung der azathioprin-therapie
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
WO2006121912A3 (en) Diagnostic methods for the detection of risk of neurodevelopmental disorders
WO2006002240A3 (en) Computer systems and methods for constructing biological classifiers and uses thereof
WO2007050588A3 (en) Systems and methods for characterizing conditions of organs for transplantation
WO2005093413A3 (en) Diagnosis and treatment of preeclampsia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties